gci

ALERT: Senators Propose a Bill for Greater Cosmetic Regulatory Oversight

Contact Author
Close
Fill out my online form.

Read more regulatory stories here.

Member of the Senate have proposed a bill that seeks a harmonized cosmetic regulation in the United States under the U.S. Food and Drug Administration (FDA). Senators Dianne Feinstein (D-California) and Susan Collins (R-Maine) introduced the Personal Care Products Safety Act to the Senate Health Committee on Apr. 20, 2015. The bill requests greater regulatory oversight for cosmetic products and ingredients from the FDA and looks to the FDA to review of five cosmetic ingredients a year.

Currently, regulation for cosmetic products in the United States varies by state. The act attempts to harmonize that regulatory system under the FDA, and it is backed by the Personal Care Products Council (PCPC), an cosmetics industry trade association.

“We look forward to continuing our work with Senator Feinstein, Senator Collins, members of the Health, Education, Labor and Pensions (HELP) Committee and other relevant stakeholders to further strengthen the bill and move it forward in Congress. And, we remain firmly committed to ensuring FDA has the appropriate funding, resources and administrative authority over our products for the 21st Century,” noted Lezlee Westine, CEO and president of the PCPC.

Funding for the FDA's increased cosmetic regulatory oversight would come from the cosmetics industry. Cosmetic manufacturers would have to register with the FDA and comply with good manufacturing practices. In addition, they would have to submit ingredient statements, report adverse events and provide safety records.

A hearing by the committee will determine if the bill can move to the Senate.